Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Corcept nets $49.1mm in IPO

Executive Summary

Corcept Therapeutics (drugs for neurological and psychiatric diseases) completed its initial public offering, netting $49.1mm through the sale of 4.5mm common shares priced at $12 each. The company had originally hoped to raise $85mm, offering 5mm shares priced between $15-17 apiece.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies